Halper Sadeh LLC Conducts Investigation into AKRO, CCRD, and PBBK for Shareholder Interests

Written by Emily J. Thompson, Senior Investment Analyst

Source: Globenewswire

Updated: Oct 22 2025

0mins

Should l Buy ?

Source: Globenewswire

Investigation of Companies: Halper Sadeh LLC is investigating Akero Therapeutics, CoreCard Corporation, and PB Bankshares for potential violations of federal securities laws and breaches of fiduciary duties related to their proposed sales.
Akero Therapeutics Sale: Akero shareholders are set to receive $54.00 per share in cash and a Contingent Value Right for an additional $6.00 upon regulatory approval of efruxifermin by June 30, 2031.
CoreCard Corporation Sale: CoreCard shareholders will receive an exchange ratio of Euronet common stock between 0.2783 and 0.3142 for each share they own.
PB Bankshares Sale: PB Bankshares shareholders can choose to receive either 0.7850 shares of Norwood common stock or $19.75 in cash for each share they own, with Halper Sadeh LLC offering legal support to shareholders regarding their rights and options.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

GET FREE REAL TIME NOTIFICATIONS

Stock Monitor for NVDA?

Get Started Free

FREE STOCK RECOMMENDATIONS DAILY

Stock Bullish Tomorrow

Get Started Free

70% BACKTESTED ACCURACY!

Should I Buy NVDA?

Get Started Free